Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure

BACKGROUND: High rates of HBeAg and/or HBsAg seroconversion or clearance have been achieved in chronic hepatitis B (CHB) patients receiving pegylated interferon (pegIFN) in addition to ongoing nucleos(t)ide analogue (NUC) treatment. In the present study, we aimed to evaluate HBsAg kinetics to predic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Med Sci Monit
Asıl Yazarlar: Chen, Qing, Zhang, Jun, Huang, Jianjun, Quan, Bin, Wu, Xiaoxin, Deng, Shengming, Han, Wenzheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: International Scientific Literature, Inc. 2019
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6604672/
https://ncbi.nlm.nih.gov/pubmed/31230063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.916441
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller